Smarter Cell Culture Starts with Better Media

In the early 1980s, the author, a graduate student, contributed to a cell-culture lab as part of their funding arrangement. They mixed media with familiar ingredients like amino acids, along with less comprehensible components such as chick-embryo extract and horse serum. The concept of media optimization at the time was essentially to purchase the same horse serum from the same herd for each batch.

Today, media optimization is a complex scientific discipline, influencing various aspects of cell culture from research to biomanufacturing.

The composition of culture media directly impacts cell growth, productivity, product quality, impurity profiles, downstream purification, and manufacturing economics. As biologics manufacturers strive for intensified production processes, optimizing media has become a critical and intricate challenge. Researchers like Bhanu Chandra Mulukutla, PhD, and Wenge Wang, PhD, emphasize the importance of understanding the cells and the desired product, along with their distinct nutritional needs and metabolic behaviors.

Developers must balance multiple priorities, including robust cell growth, maximizing productivity, preserving product quality, minimizing impurities, and ensuring downstream purification efficiency. A common misconception is that adding more nutrients inherently results in better media. However, every nutrient has an optimal operating window.

Cells sense nutrient levels, and both inadequate and excessive concentrations can be detrimental. Excess glucose, for instance, can disrupt metabolic processes, reduce productivity, alter protein quality, and generate unwanted waste products.

As production intensifies, higher nutrient requirements pose challenges due to the poor solubility of several amino acids. This leads to difficulties in formulation, increased complexity in mixing procedures, slower filtration, longer preparation times, and higher risks of precipitation. These complexities result not only from biological factors but also from chemical and manufacturing practicality considerations.

In intensified fed-batch manufacturing, the stakes are higher. Higher viable cell densities and sustained elevated productivity over longer runs demand increased nutritional support. However, supplying all necessary nutrients without excessive feed additions becomes a delicate balance. Manufacturers often rely on multiple feeds, especially for poorly soluble amino acids like tyrosine and cysteine, and branched-chain amino acids such as leucine, isoleucine, and valine, which cells consume quickly and have relatively low solubility.

While adequate nutrition is crucial, waste accumulation is another concern. In intensified fed-batch processes, nutrients are continually added without removing spent media. Over 12 to 14 days, metabolic byproducts accumulate, potentially inhibiting cell growth, reducing productivity, and affecting product quality. Additionally, host-cell proteins can reach elevated concentrations, creating purification challenges and potential product stability issues.

Pfizer has shifted from a media-centric approach to a broader systems-level strategy. After extensive research using omics technologies and systems biology, they identified pathways responsible for generating problematic metabolic byproducts. This understanding has led to new engineering approaches, such as maintaining nutrient concentrations near their optimal healthy ranges and modifying cellular metabolism.

By optimizing nutrient levels, cells can utilize them effectively for growth and protein production instead of forming unwanted byproducts. These strategies help developers achieve the desired balance of productivity, cell health, impurity control, manufacturability, and final product quality.